International Patent: ENTERAL DELIVERY OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS

GENEVA, July 2 -- ABLYNX NV filed a patent application (EP2025/088347) for “ENTERAL DELIVERY OF IMMUNOGLOBULIN SINGLE VARIABLE DOMAINS”. With publication no. WO/2026/132417, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/24

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....